Erythrovirus and its applications
US7291452B1 · kind B1 · utility
10Cited by
0References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1998 |
| Grant date | Nov 6, 2007 |
| Priority date | — |
| Expiry date | Dec 3, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns nucleic acids derived from human V9 erythrovirus, fragments thereof, encoded polypeptides, and applications as diagnostic reagents and as immunogenic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.